Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr175.50 DKK
Change Today -4.50 / -2.50%
Volume 74.6K
As of 11:04 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

ambu a/s-b (AMBUB) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - kr196.00
52 Week Low
05/20/14 - kr82.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AMBU A/S-B (AMBUB)

Related News

No related news articles were found.

ambu a/s-b (AMBUB) Related Businessweek News

No Related Businessweek News Found

ambu a/s-b (AMBUB) Details

Ambu A/S provides healthcare solutions in anesthesia, patient monitoring and diagnostics, and emergency care fields worldwide. The company offers anesthesia products, including laryngeal masks, ventilation bags, face masks for artificial ventilation, scopes for visualization, anesthesia tubes, and pumps for palliative care; patient monitoring and diagnostics products, such as single-use electrodes for neurological and cardiological examinations, and tubes and needles; emergency care products comprising neck collars, manikins, and other equipment for first-aid training; conductive adhesive gels for use in the production of skin-contacting biomedical electrodes; and single-use videoscopes. The company serves hospitals, clinics, rescue services and sleep laboratories, aid organizations, and the armed forces. It sells and exports its products through direct sales and distributors. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

2,350 Employees
Last Reported Date: 02/2/15
Founded in 1937

ambu a/s-b (AMBUB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ambu a/s-b (AMBUB) Key Developments

Ambu A/S Announces Unaudited Earnings Results for the First Quarter Ended December 31, 2014 ; Revises Financial Guidance for 2014/15

Ambu A/S announced unaudited earnings results for the first quarter ended December 31, 2014. For the quarter, the company reported revenue of DKK 388 million compared to DKK 342 million a year ago. Operating profit was DKK 15 million compared to DKK 16 million a year ago. Profit before tax was DKK 11 million compared to DKK 4 million a year ago. Net profit for the period was DKK 8 million compared to DKK 3 million a year ago. Basic and diluted EPS was DKK 0.17 compared to DKK 0.06 a year ago. Cash flows used in operating activities were DKK 16 million compared to cash flows from operating activities of DKK 20 million a year ago. Purchase of non-current assets was DKK 34 million compared to DKK 17 million a year ago. Return on equity was 2.9% compared to 3.2% a year ago. For the full year of 2014/15, the company expects revenue of approx. 16%, EBIT margin of approx. 12.5%, free cash flows of Approx. DKK 130-140 million against previously expected revenue of approx. 10%, EBIT margin of approx. 12.5%-13%, free cash flows of Approx. DKK 130-140 million.

Ambu A/S, Q1 2015 Earnings Call, Feb 02, 2015

Ambu A/S, Q1 2015 Earnings Call, Feb 02, 2015

Ambu A/S Presents at SEB Nordic Seminar, Jan-09-2015 10:10 AM

Ambu A/S Presents at SEB Nordic Seminar, Jan-09-2015 10:10 AM. Venue: Hilton Copenhagen Airport Hotel, Copenhagen, Denmark.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMBUB:DC kr175.50 DKK -4.50

AMBUB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Repro-Med Systems Inc $0.42 USD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation AMBUB Industry Range
Price/Earnings 47.9x
Price/Sales 4.5x
Price/Book 8.9x
Price/Cash Flow 41.1x
TEV/Sales 3.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMBU A/S-B, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at